Volume 23, Issue 1, Pages (January 2015)

Slides:



Advertisements
Similar presentations
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Advertisements

Christina K. Marko, Balaraj B. Menon, Gang Chen, Jeffrey A
TRPV1 Involvement in Inflammatory Tissue Fibrosis in Mice
Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis  Dariush Haghmorad, Mohammad Bagher.
From: Neutralization of Ocular Surface TNF-α Reduces Ocular Surface and Lacrimal Gland Inflammation Induced by In Vivo Dry Eye Invest. Ophthalmol. Vis.
Third-party Mesenchymal Stem Cells Improved Human Islet Transplantation in a Humanized Diabetic Mouse Model  Hao Wu, Di Wen, Ram I Mahato  Molecular Therapy 
Lung Epithelial Cell–Specific Expression of Human Lysosomal Acid Lipase Ameliorates Lung Inflammation and Tumor Metastasis in Lipa−/− Mice  Ting Zhao,
Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in HypertensionNovelty and Significance by Kandarp H. Shah, Peng Shi, Jorge F. Giani, Tea.
Volume 25, Issue 2, Pages (August 2006)
Loss of Extracellular Superoxide Dismutase Induces Severe IL-23-Mediated Skin Inflammation in Mice  Yun Sang Lee, In-Su Cheon, Byung-Hak Kim, Myung-Ja.
Volume 78, Issue 11, Pages (December 2010)
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Priti Agarwal, Mehdi Rashighi, Kingsley I. Essien, Jillian M
Restoration of Corneal Transparency by Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus- Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
The Protective Effects of Melittin on Propionibacterium acnes–Induced Inflammatory Responses In Vitro and In Vivo  Woo-Ram Lee, Kyung-Hyun Kim, Hyun-Jin.
by Éric Aubin, Réal Lemieux, and Renée Bazin
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity  Sang E. Lee, Ji-Min.
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 82, Issue 8, Pages (October 2012)
Oral Administration of Poly-γ-Glutamate Ameliorates Atopic Dermatitis in Nc/Nga Mice by Suppressing Th2-Biased Immune Response and Production of IL-17A 
Volume 18, Issue 5, Pages (May 2010)
Volume 8, Issue 5, Pages (May 2017)
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 18, Issue 10, Pages (October 2010)
Volume 25, Issue 11, Pages (November 2017)
Volume 17, Issue 12, Pages (December 2016)
Culture medium from TNF-α–stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms  Wenru Su, MD,
Volume 70, Issue 12, Pages (December 2006)
Volume 13, Issue 1, Pages (January 2006)
Volume 143, Issue 1, Pages (July 2012)
Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation  Ji H. Lee, Yun S. Lee, Eun-Jung Lee, Ji.
Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3- Dioxygenase and Bystander M2 Macrophage Differentiation  Moïra François, Raphaëlle.
Third-party Mesenchymal Stem Cells Improved Human Islet Transplantation in a Humanized Diabetic Mouse Model  Hao Wu, Di Wen, Ram I Mahato  Molecular Therapy 
Ryang Hwa Lee, Nara Yoon, John C. Reneau, Darwin J. Prockop 
Volume 25, Issue 8, Pages (August 2017)
Volume 73, Issue 7, Pages (April 2008)
Molecular Therapy - Nucleic Acids
Volume 18, Issue 9, Pages (September 2010)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Volume 20, Issue 11, Pages (November 2012)
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 26, Issue 1, Pages (January 2018)
Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.
Volume 11, Issue 3, Pages (September 2018)
Volume 18, Issue 4, Pages (April 2010)
Wei-Yun Lai, Bo-Tsang Huang, Jen-Wei Wang, Pei-Ying Lin, Pan-Chyr Yang 
Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge 
Volume 17, Issue 2, Pages (February 2009)
Oral Administration of Poly-γ-Glutamate Ameliorates Atopic Dermatitis in Nc/Nga Mice by Suppressing Th2-Biased Immune Response and Production of IL-17A 
Jun Asai, Hideya Takenaka, Norito Katoh, Saburo Kishimoto 
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 66, Issue 3, Pages (September 2004)
Volume 20, Issue 1, Pages (January 2012)
Volume 131, Issue 6, Pages (December 2006)
Volume 26, Issue 1, Pages (January 2018)
Volume 32, Issue 1, Pages (January 2010)
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
Volume 27, Issue 4, Pages (October 2007)
Moutih Rafei, Elena Birman, Kathy Forner, Jacques Galipeau 
Volume 25, Issue 4, Pages (April 2017)
CD28 Aptamers as Powerful Immune Response Modulators
Volume 25, Issue 6, Pages (June 2017)
Volume 13, Issue 11, Pages (December 2015)
Volume 18, Issue 10, Pages (October 2010)
Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge 
Volume 12, Issue 5, Pages (November 2005)
Volume 25, Issue 4, Pages (April 2017)
Presentation transcript:

Volume 23, Issue 1, Pages 139-146 (January 2015) Mesenchymal Stem/Stromal Cells Protect the Ocular Surface by Suppressing Inflammation in an Experimental Dry Eye  Min Joung Lee, Ah Young Ko, Jung Hwa Ko, Hyun Ju Lee, Mee Kum Kim, Won Ryang Wee, Sang In Khwarg, Joo Youn Oh  Molecular Therapy  Volume 23, Issue 1, Pages 139-146 (January 2015) DOI: 10.1038/mt.2014.159 Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Establishment of inflammation-induced dry eye in mice. (a) Concanavalin A (ConA) was injected into an intraorbital space in mice. Phosphate-buffered solution (PBS) was injected as vehicle control. One week later, the tissues were subjected to assays. (b) Immunostaining showed extensive infiltration of CD3+ T cells in the intraorbital gland. (c) Aqueous tear production as measured by phenol red thread test was significantly reduced by ConA injection. (d,e) Real-time RT-PCR assay showed that either 10 or 20 μl injection of ConA (10 mg/ml) significantly increased the levels of IL-2 and IFN-γ transcripts which are the cytokines derived from activated T cells. (f) In the ocular surface including the cornea and conjunctiva, the levels of IL-2 and IFN-γ transcripts were increased by ConA injection (10 mg/ml, 20 μl), while the levels of TNF-α, IL-1β, and IL-6 were not affected. (g) The corneal dye staining indicated the development of corneal epithelial erosion in ConA-injected eyes. n = 10 to 20 in each group. The data are presented as the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. Molecular Therapy 2015 23, 139-146DOI: (10.1038/mt.2014.159) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Effects of mesenchymal stem/stromal cells in inflammation-induced dry eye. (a) After concanavalin A (ConA) injection (10 mg/ml, 20 μl), human or mouse bone marrow-derived mesenchymal stem/stromal cells (hMSC, mMSC; 1 × 103 or 1 × 105 cells/20 μl balanced salt solution; BSS), human dermal fibroblasts (hFb; 1 × 105 cells/20 μl BSS), or BSS were administered periorbitally. One week later, the tissues were subjected to assays. (b) The amount of aqueous tear production as assayed by phenol red thread test was significantly higher in the hMSC- or mMSC-treated eyes, compared to the BSS- or hFb-treated eyes. (c,d) The levels of IL-2 and IFN-γ transcripts were significantly lower in the intraorbital gland and ocular surface of the hMSC- or mMSC-treated group. However, the levels of IL-2 and IFN-γ were markedly increased in the hFb-treated eyes. (e) The corneal epithelium had severe punctate erosions in the BSS-treated control, and the corneal staining score was lower in the hMSC- or mMSC-treated eyes than in the BSS- or hFb-treated eyes. n = 10–20 in each group. The data are presented as the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. Molecular Therapy 2015 23, 139-146DOI: (10.1038/mt.2014.159) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Histologic and flow cytometric analyses of the intraorbital gland. (a) Representative picture of hematoxylin-eosin staining showed disruption of the intraorbital gland structure with extensive acinar atrophy and periductal infiltration of inflammatory cells 7 days after concanavalin A (ConA) injection (10 mg/ml, 20 μl). Most of the infiltrating inflammatory cells were CD3+ T cells. In contrast, the structure of the intraorbital gland was well preserved with few inflammatory infiltrates by treatment with human or mouse bone marrow-derived mesenchymal stem/stromal cells (hMSC, mMSC). (b) Flow cytometric analysis of cells revealed that the percentages of CD4+ cells or IFN-γ+CD4+ cells in the intraorbital gland were increased by ConA injection, and significantly reduced by treatment with hMSC. The data are presented as the mean ± SEM. *P < 0.05; **P < 0.01. Molecular Therapy 2015 23, 139-146DOI: (10.1038/mt.2014.159) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 PAS staining of the conjunctiva. (a) Representative photograph of Periodic Acid Schiff (PAS) staining of the conjunctiva showed that the number of goblet cells was markedly reduced by concanavalin A (ConA) injection (10 mg/ml, 20 μl), and improved by treatment with human or mouse bone marrow-derived mesenchymal stem/stromal cells (hMSC, mMSC). (b) The goblet cell counts in the conjunctiva were significantly higher in the hMSC- or mMSC-treated eyes, compared to the BSS-treated controls. The data are presented as the mean ± SEM. **P < 0.01; ***P < 0.001. Molecular Therapy 2015 23, 139-146DOI: (10.1038/mt.2014.159) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Effects of mesenchymal stem/stromal cells on T-cell proliferation and differentiation. (a) Fluorescence carboxyfluorescein succinimidyl ester (CFSE)-labeled murine CD4+ cells were stimulated with ConA (5 μg/ml), and co-cultured with human bone marrow-derived mesenchymal stem/stromal cells (hMSC) in transwell for 5 days. Flow cytometry to detect CFSE dilution showed that CD4+ cell proliferation was significantly suppressed by co-cultures with hMSC. (b) CFSE-labeled murine CD4+ cells were stimulated with anti-CD3/CD28 antibodies (2.5 μg/ml), and co-cultured with either hMSC or human dermal fibroblasts (hFb) for 5 days. CD4+ cell proliferation was significantly suppressed by co-cultures with hMSC, but not by hFb. (c) CD4+ cells were co-cultured with hMSC in transwell for 5 days in the presence of IL-1β and IL-23, and evaluated for IFN-γ expression by flow cytometry. Flow cytometry demonstrated that hMSC markedly reduced the percentage of IFN-γ–secreting cells indicating the suppression of Th1 differentiation by hMSC. n = 3 in each group. Data are presented in mean ± SD and represent three independent experiments. *P< 0.05; ***P < 0.001. Molecular Therapy 2015 23, 139-146DOI: (10.1038/mt.2014.159) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions